3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
2
Sponsor Class
OTHER
7
NETWORK
2
NIH
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Multiple Myeloma
11
Neuroblastoma
7
Lymphoma
7
Neoplasms, Plasma Cell
5
Immunoglobulin Light-chain Amyloidosis
5
Hodgkin Disease
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic Syndromes
3
Leukemia, Myeloid, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Leukemia
3
Ganglioneuroblastoma
3
Waldenstrom Macroglobulinemia
2
Sarcoma, Ewing
2
Preleukemia
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Neoplasms
2
Lymphoproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Lymphatic Diseases
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, B-Cell
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Interventions
Vincristine
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
Cyclophosphamide
3
Surgical Procedures, Operative
2
Specimen Handling
2
Radiotherapy
2
Melphalan
2
Irinotecan
2
Busulfan
2
regorafenib
1
irinotecan sucrosofate
1
X-Rays
1
Trabectedin
1
Temozolomide
1
Radiation
1
Phantoms, Imaging
1
Magnetic Resonance Spectroscopy
1
Fluorodeoxyglucose F18
1
Dactinomycin
1
Bone Density
1
Biopsy
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Sarcoma, Ewing
×
Melphalan
×
Clear all
NCT02063022
2022-09-19
EW-1
Italian Sarcoma Group
Phase 3
Completed
278 enrolled
NCT02727387
2022-09-19
EW-2
Italian Sarcoma Group
Phase 2
Completed
155 enrolled